Horizon Therapeutics Public Ltd Co

AMERIPRISE FINANCIAL INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

120,430

Value ($000)

14,011

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	14,011	0.0%	120,430	9/30/2023
2023 Q2	8/14/2023	74,796	0.0%	727,214	6/30/2023
2023 Q1	5/22/2023	27,537	0.0%	252,302	3/31/2023
2022 Q4	2/14/2023	230,652	0.1%	2,026,721	12/31/2022
2022 Q3	11/14/2022	189,448	0.1%	3,070,573	9/30/2022
2022 Q2	8/15/2022	204,427	0.1%	2,569,012	6/30/2022
2022 Q1	5/16/2022	138,996	0.0%	1,320,991	3/31/2022
2021 Q4	2/14/2022	230,308	0.1%	2,138,133	12/31/2021
2021 Q3	11/15/2021	280,046	0.1%	2,555,160	9/30/2021
2021 Q2	8/16/2021	260,629	0.1%	2,786,776	6/30/2021
2021 Q1	5/17/2021	251,777	0.1%	2,730,327	3/31/2021
2020 Q4	2/12/2021	105,789	0.0%	1,447,083	12/31/2020
2020 Q3	11/16/2020	120,908	0.0%	1,552,013	9/30/2020
2020 Q2	8/14/2020	77,534	0.0%	1,387,940	6/30/2020
2020 Q1	5/15/2020	60,417	0.0%	2,039,183	3/31/2020
2019 Q4	2/14/2020	118,082	0.0%	3,257,782	12/31/2019